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TRANSPLANT ATION OF THE LIVER 
IN HUMAN SUBJECTS 
THOMAS E. STARZL and CHARLES .. w. PUTNAM: 
In this chapter, the usual practice has been 
omitted of devoting a section to historical 
background. The reason is that the first re-
port by Welch 1 of whole-organ hepatic trans-
plantation in animals was only 17 years ago. 
Furthermore, the first clinical attempts at 
liver transplantation were not made until 
1963 .. 2 Consequently, these as well as most of 
. the other early articles on liver transplanta-
tion are still of current interest. A complete 
bibliography of this subject through early 
1969 is available in a recently published 
text.s 
KINDS OF OPERATIONS 
Auxiliary Transplantation 
There are two general approaches to 
transplantation of the liver. With one 
method, an extra liver is. inserted at an 
ectopic site without removal of the diseased 
nath'e organ. This was the procedure that 
Welch 1 developed in dogs with the ultimate 
objective of treating patients who were dying 
of cirrhosis or other non-neoplastic hepatic 
diseases. 
One technique used for auxiliary hepatic 
transplantation as adapted to human sub-
jects is depicted in Figure 1. Here, the extra 
liver is placed in the right paravertebral gut-
ter or right pelvis. Its hepatic arterial supply 
is derived from the aorta or an iliac branch. 
Venous inflow is reconstituted by anastomos-
ing the distal inferior vena cava or a distal 
iliac vein to the homograft portal vein. Out-
flow is into the inferior vena cava. In the pa-
tient Whose operation is shown, portacaval 
shunt (stage I) for the control of variceal 
llemorrhage was carried out 3 days prior to 
the transplantation. 
At first thought, the use of auxiliary homo-
grafts for the treatment of benign hepatic 
disease has a special appeal. First, sacrifice of 
the remaining, albeit limited. function of the 
failing recipient liver can be avoided. Thus, 
in the event of poor initial performance by 
the homograft due to ischemia or to a severe 
but reversible rejection, it might be hoped 
that some assistance would be provided by 
the diseased host liver during a transition re-
covery period. This would be predicted to 
be a particularly significant advantage in pa-
tients with biliary atresia, since the synthesiz-
ing functions of the liver are often retained 
until the terminal stages of this disease. Sec-
ond, it was initially assumed that the place-
ment of an extra li\'er would be safer and 
technically less demanding than the ortho-
topic procedure. 
In actual practice, auxiliary transplanta~ 
tion has lost much favor. The results in 
animals have been inferior to those with 
liver replacement, partly because coexisting 
livers have the capacity to damage each other 
to a variable degree, according to which 
organ is the "dominant" one. Factors favor-
ing dominance include a splanchnic source 
of the blood for portal venous inflow, perfect 
biliary drainage, optimal total hepatic blood 
flow. and unimpeded venous outRow. An 
auxiliary canine liver graft, which does not 
enjoy these advantages relative to the host 
liver, undergoes rapid atrophy by mecha-
nisms that have been ascribed to "interliver 
competition." A detailed discussion of this 
fascinating topic has been published.3 
Here, it will only be noted that most pa-
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FIG. 1. One technique of clinical cuxiliary liver transplantation. (A) Incisions used for two 
closely spaced operations. (Bl Stage 1, an emergency portacaval shunt was .. performed prior to 
transplantation for the control of massive hemorrhage from esophageal varices, eCl A com-
pleted auxiliary transplantation. The portal venous inflow is derived from the distal inferior 
vena cava. The hepatic arterial source is from the aorta. (From Halgrimson. AMA Arch. Surg. 
93: 107, 1966.) 
tients who would be candidates for liver 
transplantation do not have adequately func-
tioning livers, so that the concept of com-
petition may not be a critical one in clinical 
practice. N eyertheless, auxiliary liver trans-
plantation for the indication of hepatic 
failure has not yet resulted in the significant 
prolongation of life for any patient. The 
reasons for failure have been several. In 
many cases good initial homograft function 
was not obtained due to ischemic injury dur-
ing and after donor death. In others, the 
presence of an extra organ within the abdo-
men was not well tolerated with restriction 
of diaphragmatic movement and consequent 
lethal pulmonary complications, Finally, the 
expectation that the placement of an extra 
organ would be technically simpler than 
with liver replacement has not been borne 
out by actual experience, as evidenced hy 'an 
. extremely high incidence of mechanical com-
plications. Because of the poor clinical re-
sults, the number of attempts at human aux-
iliary transplantation has declined to the 
point that this kind of operation will not be 
considered further in the rest of the chapter. 
Orthotopic Transplantation 
In contrast, there is mounting evi-
dence that the operation of orthotopic he-
patic transplantation (liver replacement) will 
play an increasing role in the fu ture treat-
ment of liver disorders. \Vith this procedure. 
the diseased host liver is removed, creating a 
~pace into which a graft is transplanted with 
as normal an anatomical reconstruction as 
pos~ihfeK Survival in dogs and human sub-
jects has been achieved exceeding 8Y2 and 
plK~ ,'ears, respectively. The remarks in suc-
c~;ding sections will pertain to orthotopic 
transplantation as opposed to the auxiliary 
operation just discussed. 
PREOPERATIVE 
PREPARATION 
Virtually all prospective liver reCIpI-
ents are poor risks for a major operation, 
and many of those with hepatic failure from 
non-neoplastic diseases appear at first evalua-
tion to be hopeless. Symptomatic relief may 
be obtained by the performance of proce-
dures such as paracentesis or thoracocentesis. 
Hut. unfortunately, there is probably little 
of real ,·alue that can be done to reduce the 
consequent operative hazards short of pro-
viding liver tissue. 
. It has been suggested that one way of 
transiently increasing liver function before 
the definitive procedure would be with ex 
,ivo hepatic support, using an extracorporeal 
heterologous liver in the way described by 
f.iseman.4 To our knowledge, such an ap-
proach to preoperative resuscitation has not 
yet been tried prior to transplantation. One 
Teason is that even patients near death from 
complications of hepatic disease can be 
brought through the transplantation proce-
dure with almost immediate improvement 
providing the homograft functions properly 
and promptly. 
The paradoxical ability of these moribund' 
recipients to survive such major surgery may 
be related partly to the troublesome opera-
tive bleeding which is almost invariably en-
tDunlered. The consequent necessity for 
major blood replacement frequently results 
in intraoperative exchange transfusions of at 
bst the magnitude that have been reported 
by Trey. Burns, and Saunders of Cape Town 
to be of benefit in acute liver insufficiencyJj 
~e: coincidental therapeutic effect of mas-
·"-e transfusion, as well as the immediate 
benefits of good hepatic {unction by the 
transplant. have usually resulted in patients 
n-turning to the ward in better condition 
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than at the time of their departure. 
This tloes not mean that efforts should be 
discontinued to find a better means of ex 
vivo hepatic support. At the present time, 
only a small fraction of patients who might 
be candidates for liver transplantation can 
actually be treated, since there are no means 
of providing therapy analogous to that with 
the artificial kidney which can tide oyer pros-
pective recipients while an organ is being 
found_ Until an artificial lh-er is developed 
that will provide some of the more crucial 
hepatic functions, liver transplantation will 
not be able to achieve anything like its true 
potential. 
Although little can be done for the pre-
existing liver failure, secondary abnormali-
ties of other organs can sometimes be effec-
tively ameliorated. For example, the effects 
of renal failure secondary to the hepatorenal 
syndrome can be treated with the artificial 
kidney_ Pulmonary manifestations may be 
improved by simple tracheobronchial toilet, 
particularly if aspiration has occurred. Trans-
fusions of blood or albumin may be useful 
for the correction of blood volume or other 
fluid space abnormalities. If fresh whole 
blood, fresh frozen plasma, or platelets are 
judiciously given, some improvement in co-
agulation may be possible. 
CASE SELECTION 
According to Underlying 
Disease 
Hepatic malignancy. 'Vhen ortho-
topic liver transplantation was first attempted 
in humans, hepatoma was considered to be 
an outstanding indication for proceeding_ 
There were some minor reasons for this atti-
tude, including the fact that the state of liver 
failure and the development of venous col-
laterals would on the average be less than in 
patients with end-stage non-neoplastic he-
patic disorders. The major rationale was, 
however, that complete removal of the recipi-
ent liver was an obligatory component of the 
undertaking if cure was to be achieved. Thus, 
liver replacement was conceived of as a 
means of extending the limits of resectability 
in patients who did not have extrahepatic 
1250 TRANSPLANTATION OF THE LIVER IN HUMAN SUBJECTS 
R L 
III...,.. 
. : • 
p A 
A B c o 
FIG. 2. 99M technetium liver scans in a patient whose indication for transplantation was hepa-
toma. Note progressive invasion of liver homograft by tumor beginning at 94 days. The patient 
died of carcinomotosis 143 days post-transplantation. At autopsy, the homograft was almost 
completely replaced with carcinoma. (From Starzl. Experience in Hepatic Transplantation. Cour-
tesy of W. B. Saunders, Philadelphia, 1969.) 
spread of their tumors. 
Actual experience with liver replacement 
for the indication of an hepatic malignant 
lesion has not supported this reasoning and, 
in fact, has led us to declare a moratorium on 
such cases. At the University of Colorado, a 
total of 14 patients have undergone liver re-
placement for primary hepatic malignancy. 
In seven cases, the attempt was "successful" 
in ·a technical sense, and with survival for at 
least 2Y2 postoperative months. Six of the 
seven recipients developed a recurrence of 
the malignant lesion from 2 to 13 months 
later. Eventually, these six patients died, and 
in most instances the tumor recurrence either 
caused death or contributed to it in an im-
portant way (Fig. 2). Lethal and widespread 
metastases were responsible for death as early 
as 143 days after operation and as late as 
14 months. 
Hepatoma was the histopathological diag-
nosis in all but one of the foregoing seven 
cases with extended postoperatiye follow-up. 
The exceptional patient had a hemangio-
endotheliosarcoma. Although he made a satis-
fac·tory recovery from operation, he also de-
veloped widespread metastases and died in 
less than 4 months. 
\Ve have suggesterl 3 that the immuno-
suppressive therapy necessary to prevent re-
jection may itself have contributed to the 
aggressiveness of the metastatic growth. Such 
speculations are based in one way or another 
on the surveillance hypothesis of cancer pro-
posed by Thomas 6 and Burnet,' which holds 
that the immune system is an important fac-
tor in the limitation of growth of mutant 
neoplastic cells. \Vhether immunosuppres-
sion contributed to the unsuccessful outcome 
under the specific conditions of liver trans-
plantation cannot be proved, since' the re-
sults may only have been a reflection of the 
highly malignant natural history of these 
particular neoplasms. 
It is conceivable that other kinds of he-
patic malignant lesions with a more indolent 
natural course may be less prone to post-
transplantation reccurrence and spread. One 
example might be relatively slow-growing 
intrahepatic duct cell carcinomas. To our 
knowledge, no patient has yet been treated 
by transplantation for this kind of tumor. 
It is a bit too early to conclude once and 
for all that liver replacement in the face of 
hepatic malignancy is a futile undertaking. 
One of our patients, whose primary reason 
for liver transplantation was biliary atresia, 
had an incidental hepatoma in the total hep-
atectomy specimen. Her preoperatiyeserum 
contained almost 4 rug per 100 ml of alpha 
fetoprotein_ After operation in January 1970, 
the fetoprotein disappeared from the serum 
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FIG. 3. Alpha.fetoprotein determinations in a 3· 
yeor-old child who underwent transplantation for 
biliary atresia. A small hepatoma was discovered 
within the operative specimen. The child is now 3Y2 
years after transplantation. Alpha.feloprotein de-
terminations continue to be negative and she re-
mains free of tumor. 
(Fig. 3) and has not recurred in the 31'2 years 
of post·transplantation life. Apparently, this 
child has achieyed a cure from her hepatoma. 
Isolated cures of hepatic malignancy after 
liver replacement have also been reported by 
Roy CaIne 8. of Cambridge and by Pierre 
DaIoze- of Montreal. Nevertheless, the high 
tate of recurrence of tumor in our hands has 
made us reluctant, for the time being, to ac-
cumulate more such cases. 
Biliary atresia. Instead, the prime 
indications for orthotopic liver transplanta· 
tion have come to be terminal liver diseases 
of non·neoplastic origin. Of these, extrahe· 
patic biliary atresia is perhaps the least ques· 
tionable, since death is inevitable after a rela-
tively predictable interval and without any 
hope in the remaining life for rehabilitation. 
With intrahepatic biliary atresia, more con-
servatism is exercised, as some of these chil-
dren can survive for many years. 
Other benign diseases. The problem 
of the proper time for liver transplantation 
• Follow.up by personal communication in June 1972. 
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may be a difficult one for almost all other 
kinds of non-neoplastic liver disease. This is 
particularly so if alcoholism is a significant 
etiological factor that could be eliminated by 
abstinence. All gastroenterologists of experi· 
ence have seen occasional patients with Laen-
nec's cirrhosis who were apparently dying of 
profound hepatic failure but who recovered 
and subsequently left the hospital. Apprecia· 
tion of this fact has probably been respon-
sible for the rather small numbers of liver 
transplantations where the diagnosis is al-
coholic cirrhosis. 
The outcome is somewhat more predict-
able in patients with postnecrotic cirrhosis 
and less common disorders such as primary 
biliary cirrhosis, medically refractory Wil-
son's hepatolenticular degeneration, irrepa-
rable biliary duct injury, and some of the 
more lethal inborn errors of metabolism. But 
even with these diseases, there initially was 
reluctance for proceeding until incontrovert-
ible evidence was obtained that extended 
survival was possible in human subjects after 
liver transplantation. Now that the feasibil-
ity of long·term survival has been proved, it 
will be possible to relax the restrictions on 
intervention so that treatment may be insti-
tuted before the terminal stages of the dis-
·ease. Otherwise, it is unlikely that the results 
in future cases will be significantly improved. 
At the present time, it is our belief that all 
patients who are dying from an othen\'ise un-
treatable non·neoplastic hepatic disease are 
potential candidates for liver transplanta-
tion, providing there are not other medical 
contraindications. Such contraindications 
would include advanced age (probably above 
50 years), a history of sociopathic behavior 
that would prevent postoperative manage-
ment, preexisting and untreatable systemic 
or local infections, or serious disease of 
organs other than the liver, as, for example, 
with coexisting severe heart disease. 
According to Immunological 
Criteria 
ABO matching. When a seriously ill 
person is identified as a possible organ donor, 
the ABO blood type is determined. When 
patients are considered for receipt of the 
liver, it is considered desirable to have the 
same ABO group as the donor. Failing this, 
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Table l. DIRECTION OF ACCEPTABLE 
l\lISMATCHED TISSUE TRANSFER 
o to non-oa 
Rh- to Rh+ 
Rh+ to Rh-
A to non·A 
B to non·B 
AS to non·ASb 
aO is universal donor. 
bAB is universal recipient. 
Safe 
Safe 
Relatively safe 
Dangerous 
Dangerous 
Dangerous 
\ 
the rules of tissue transfer are followed which 
are summarized in Table 1. The guide lines 
are designed to avoid the transplantation of 
an organ into a recipient who possesses pre-
formed antidonor isoagglutinins. Erythrocyte 
antigens against which these isoagglutinins 
react are found not only in erythrocytes 
but also in most nucleated cells includ-
ing hepatocytes. Thus, violation of the rules 
of tissue transfer in Table 1 can result in an 
acute immunological insult to a graft and 
even to immediate rejection.9 
HL·A matching. Several years ago, 
it was hoped that dinical results after liver 
transplantation might be improved by effec· 
tive donor·recipient matching of histocom-
pa.tibility . (HL-A) antigens. Unfortunately, 
the results obtained so far with hepatic, car-
diac, and renal transplantation have not cor-
related well with the quality of the matches. 
These findings in our own experience and in 
that of others have led us, for the moment, to 
ignore the question of HL-A matching for 
liver transplantation. Nor do we even use the 
most favorable matching as an instrument of 
selection amongst a given group of candi-
dates for transplantation. At the present 
time, our major criterion concerns who has 
the most pressing need. 
DONOR PROCUREMENT 
One of the important advances in 
transplantation has been social in nature, 
consisting of acceptance by the public of the 
concept of cadaveric organ removal. In the 
United States and many other countries,. this 
acceptance has led to a sharpening and liber-
alization of the criteria of death in accor-
dance with the concept of irreversible brain 
injury. If brain death is accepted, one of the 
most serious problems in organ transplanta-
tion is vi.rtually eliminated, since the interval 
of normothermic ischemic injury subsequent 
to cardiac arrest is reduced essentially to zero 
inasmuch as the dissection prior to the reo 
moval of the liver or other organs can be car-
ried out or even completed in the presence 
of an effective circulation. 
With or without the advantages conferred 
by the acceptance of brain death, it is pos-
sible to maintain a well perfused liver in situ 
up to the moment of its excision. One way of 
achieving this, even in a patient who has suf-
fered an irreversible cardiac arrest, is by the 
rapid insertion of cannulas through a fe-
moral artery and vein into the great ab-
dominal vessels. A patient may then be con-
nected to a cardiopulmonary bypass. With a 
heat exchanger interposed in the circuit, the 
cadaver may be simultaneously perfused and 
cooled (Fig. 4). Finally, refinements in tech· 
nology have made possible the successful 
preservation of canine and human livers for 
many hours after their excision and inser-
tion into perfusion chambers.3 "With these 
various advances, all achieved within the last 
decade, it is hardly excusable today to carry 
out a liver transplantation with an organ 
that has· been significantly injured either 
before or after death. 
OPERATIVE PROCEDURES 
Donor Hepatectomy 
The essential feature of liver removal 
is extremely straightforward and consists of 
skeletonization of the structures entering and 
leaving the liver. Frequently, the first step 
upon entering the abdomen and after exam-
ining the liver is incision of the restraining 
ligaments of the ~iverK The falciform liga-
ment is divided down to or near the entry of 
the hepatic veins (Fig. 5). The left triangular 
ligament is incised (Fig. 6), as well as the 
right triangular and coronary liga,ments 
(Fig. 7). . 
It is particularly important in freeing the 
right lobe of the liver from the bare area 
FIG. 4. Technique for postmortemextracorporecl perfusion of organ donors with a heart-lung 
machine. Catheters are inserted via the femoral vessels into the aorta and vena cava as soon 
. as possible after death. Temperature control is provided by the heat exchanger. Cross<lamping 
of the thoracic aorta partially limits perfusion to the lower part of the body. (From Storz!' 
Experience in Hepatic Transplantation, Courtesy of W. B. Saunders, Philadelphia, 1969.) 
Right 
lobe 
FIG. 5. Initial steps in donor hepatectomy. Note that the ligaments are incised as for away 
from the liver as possible so that they can be later resutured to the companion structures in 
the recipient if desired. (From Starzl. Experience in Hepatic Transplantation, Courtesy of W. B. 
Saunders, Philadelphia, 1969.) 
1253 
1254 TRANSPLANTATION OF THE LIVER IN HUMAN SUBJECTS 
FIG. 6. Donor hepatectomy (continued). Exposure and the initial dissection of the suprahepatic 
vena cava and its tributaries. After entering the row area formed by divergence of the leaves 
of the falciform and triangular ligaments, a short segment of the left hepatic vein (l.H.V.) is 
usually seen first. (From Storz!' Experience in Hepatic TraMptanlalion, Courtesy of W. B. 
Saunders, Philadelphia, 1969.) 
that the dissection be carried out sharply. 
Otherwise, subcapsular hematomas or cap-
sular tears may inadvertently be caused. As 
the right lobe of the liver is rotated into the 
wound with exposure of the bare area, the 
right adrenal vein is readily identified enter-
ing the vena cava behind the liver (Fig. 8); 
this vessel is ligated and divided. After dear-
ing loose areolar tissue away, it is usually pos-
sible to sweep behind the vena cava from 
the diaphragm to the entry of the renal veins 
without encountering resistance (Fig. 9). 
The rest of the dissection of the donor liver 
consists in isolating the structures below the 
liver as depicted in Figure 10. Usually the 
hepatic artery is dissected back to its origin 
from the celiac axis, ligating its gastroduo-
denal and right gastric branches (Fig. 10 A 
and B). A long segment of the portal vein is 
. similarly freed inferiorly to at least the en-
trance of the splenic vein (Fig. 10 C). In most 
cases, the biliary drainage procedure of cho· 
lecystoduodenostomy is planned. If this is 
contemplated, the common duct is ligated 
below the entrance of the cystic duct and an 
incision into the gallbladder is made so that 
the bile may be washed out. In experimental 
animals, failure to observe this precaution 
may lead to autolysis of the extrahepatic bili-
ary duct system during the time when the 
organ is without a circulation. 
The final step in the removal of the liver 
is further development of the cuff of vena 
cava above the liver into which empty the 
main hepatic veins (Fig. 11)_ This segment of 
vena cava is extremely short and is actually 
a confluence of vessels to form a venous 
cloaca. When the vena cava is finally tran-
sected and one peers into the liver side of 
this cloaca, the view is as shown in Figure 11 
(inset). 
With removal of the liver, infusion with a 
chilled solution is carried out via the portal 
vein (Fig. 12). In addition to cooling the 
organ, blood is washed out, thereby facilitat-
ing the anastomoses which can be perfonned 
in a dean field. There have been a number 
of infusion fluids recommended ranging from 
simple electrolyte solutions to very elabor3te 
concoctions_ 
Right 
triangular 
fig. 
FIG. 7. Donor hepatectomy (continued). Incision of 
the right triangular ligament and the onterior leaf 
of the right coronory ligament. (From Storz!' Ex-
perience in Hepatic Transplanation, Courtesy of 
W. B. Sounders, Philadelphia, 1969.) 
The Recipient Operation 
Most of the steps in the recipient are 
identical or similar to those described above 
under the donor except that the long cuffs 
are left with the patient rather than with the. 
homograft. After removal of the liver, the 
residual anatomy consists of cuffs of four ves-
sels, the common duct stump (except in bili-
ary atresia), and the raw areas left by inci-
sion of the various hepatic ligaments (Fig. 
13). The reconstruction consists of anasto-
mosing the individual vessels to the com-
panion vessels of the homograft as quickly as 
feasible. The "standard" operations are 
shown in Figure 14. 
One feature of the vascular reconstruction 
that is a special one in liver transplantation 
is the necessity to perform some of the vascu-
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lar anastomoses in cramped quarters and 
with short vessel lengths. To permit this kind 
of anastomosis, intraluminal suturing tech-
niques have been developed (Fig. IS), in 
which the principle is the formation of shoul-
ders of venous wall posteriorly with system-
atic eversion.s This has sometimes been 
done with a double posterior layer (Fig. 15) 
or more recently a single everting layer has 
been employed. 
The most commonly employed biliary re-
construction has been with cholecystoduo-
denostomy (Fig. 14), connecting the gall-
bladder to the duodenum with an external 
layer of interrupted silk and a continuous 
internal layer of catgut. More will be said 
later about alternative techniques. 
Technical Difficulties and 
Dangers 
Hemorrhage. Acute bleeding can be 
particularly troublesome during· the actual 
liver transplantation because of the portal 
hypertension that is present in nearly every 
patient. During the operation, the usual se-
quence is mechanical bleeding that can 
rapidly assume nightmare proportions if a 
severe coagulation disorder supervenes. Many 
of the normal coagulation factors that might 
help' control hemorrhage are dependent on 
the liver and are, therefore, defective to 
begin with in the diseased recipient. These 
coagulation deficiencies may become rapidly 
worse, after revascularization of an organ 
which has suffered ischemic damage, appar-
ently because of consumption of clotting 
factors by the injured graft.10 
'When hemorrhage occurs, all mechanical 
hemostatic tactics including ligature, sut'lre, 
and cautery are used until the revascularized 
ho~ograft can participate in what is hoped 
will be appropriate coagulation function. In 
our early patients, an attempt was made to 
treat such bleeding problems by administer-
ing thrombogenic agents such as epsilon 
amino caproic acid (EACA). Lately, we have 
studiously avoided such practices for reasons 
to be discussed later. Instead, complete de-
pendence is placed on natural processes for 
correction of the abnormalities. 
Anesthesia problems. The complex-
ity of anesthetic management during liver 
tram plantation is increased by the fact that 
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Adrenal 
gland 
R.H.V. 
FIG. S. Donor hepatectomy (continued). The liver is retracted to the left, opening the bare area 
of the right hepatic lobe and exposing the adrenal gland. The right adrenal vein is ligated and 
divided. This is usually the only posterior tributary to the retrohepotic vena cavo. At this stage, 
the right hepatic vein (R.H.V,) can be identified. (From Storz!' Experience in Hepatic Transplan-
tation, Courtesy of W. B. Saunders, Philadelphia, 1969.) 
FIG. 9. Donor hepatectomy (continued), After ligaling the right adrenal vein (R.a.v.), it should 
be possible to sweep the finger behind the retrohepatic vena cava from the diaphragm to the 
renal veins. If resistance is encountered, it usually indicates the presence of extra branches 
which must be ligated and divided. (From Storz!' Experience in Hepatic Transplantation, Courlesy 
of W. B. Sounders, Philadelphia, 1969.) 
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FIG. 10. Donor hepatectomy (continued). Dissection of the portal triad. (A) The gastroduodenal 
and right gastric arteries are tied off and divided. Before ligating the cammon duct, it should 
be determined that it communicates freely with the gallbladder via the cystic duct (see Fig. 8). 
(B) The hepatic artery is mobilized, uncovering the anterior surface of the portal vein. The 
coronary vein entering the left side of the portal trunk is almost always found; this tributary is 
ligated and divided. eCl Mobilization of the celiac axis. The splenic artery has not yet been 
ligated and divided. The entire celiac axis is usually retained with the homograft and in chil-
dren it may be advisable to include a segment of aorta as well. (From Starzl. Experience in 
Hepatic Transplantation, Courtesy of W. B. Saunders, Philadelphia, 1969.) 
the procedure is long, difficult, and often 
bloody. Even more importantly, it is an oper-
ation on the primary organ involved in the 
metabolism and detoxification of most com-
mon anesthetics. The task of the anesthesiol-
ogist is to adminster correctly drugs that, 
first, are not hepatotoxic and, second, do not 
depend primarily on the liver for their deg-
radation. In our cases, reliance has been 
placed mainly on combinations of volatile 
agents such as fluoroxene and nitrous oxide-
oxygen in nonexplosive concentrations. Such 
management permits use of the electrocau-
tcry, gives flexibility in lightening or deepen-
ing anesthesia, and allows anesthesia to be 
abruptly stopped if required by changing 
physiological circumstances. 
A number of swiftly changing metabolic 
conditions have to be carefully scrutinized 
during the anhepatic phase and immediately 
afterward. Since the patient is at risk from 
acute hypoglycemia, a constant infusion of 
glucose is required, and for proper control of 
the situation frequent blood sugar determi-
nations must be obtained. At the same time, 
the majority of recipients develop some ele-
ment of acute metabolic acidosis, also requir-
ing monitoring and correction. A third life-
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FIG. 11. Donor hepatectomy (continued). Dissection above the liver. (A) Development of supra-
hepatic vena caval cuff. A longer caval segment for subsequent onastomosis may be obtained 
by ligating and dividing ane or more phrenic veins on each side and by dissecting off the dia-
phragmatic reflection, as shown. (B) (Jnset) The cross-sectional appearance of the venous con-
fluence above the liver, as seen from above. The venous cloaca is formed by the iunction of the 
right and left hepatic veins with the' inferior vena cava. (From Starzl. Experience in Hepatic 
Transplantation, Courtesy of W. B. Saunders, Philadelphia, 1969') 
FIG. 12. Perfusion of the excised homograft with a chilled electrolyte solution infused through 
a catheter inserted into the portal vein. (From Storz!' Surg. Gynecol. Obstet. 117:659, 1963.) 
I \'\ ' ~DyI 
FIG. 13. Recipient operation. The operative field after removal of the diseased host liver. The 
thoraco-abdominal exposure shown is no longer employed. C.d.·common duct; H.a.-hepatic 
artery; Lv.c.-inferior vena cava; P.v.-portal vein. (From Storz!' Surg. Gyneco/. Obstet. 117:659, 
1963.) 
A. 
FIG 14 Recipient operations. (Al Usually the homograft celiac axis or common hepatic artery is 
attached to the proper or common hepatic artery of the recipient. (8) When two homograft 
arteries are present, the vessels may be individually anostomosed to branches of the recipient 
proper hepatic artery. (e) Anastomosis of the homograft aorta to the recipient aorta, in a 
pediotric recipient of a liver having a double arterial supply. In most recent cases, cholecystoduo-
denostomy has been performed for biliary drainage as shown. C.a.-celiac axis; C.d.<ommon 
duct; G.B.·gallbladder; H.a.-hepatic artery; I.V.e.·inferiar vena cava; P.v.-portal vein; 
S.m.a.-superior mesenteric artery. (From Starzl. Ann. Surg. 168:392, 1968.) 
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Step f2. 
Cross - sl:l:tion 
H 
Post. Allt. 
'Post ..... Ant. 
FIG. 15. Intraluminal suturing technique for the performance of the suprahepatic vena coval 
anastomosis. The posterior row may be fashioned in two loyer$ from within the lumen, but 
recently a single layer everting technique has been employed. (From Storz!' Surg. Gynecol. 
Obstet. 117:659, 1963.) 
threatening complication that has been fre· 
quently seen just after revascularization and 
lasting for several hours is hypokalemia. Ap-
parently, the potassium is sequestered in the 
grafts to the extent that serum potassium 
concentrations as low as 1.5 mEq per liter 
have been observed. 
RiQht a. 
fyorn SU? r..esenteri.c a.. 
FIG. 16. Fatal compression of the homograft arterial 
supply by an oversized homograft. In this patient, 
the recipient right hepatic artery originated from 
the superior mesenteric artery. The homograft celiac 
axis was therefore anastomosed directly to the re-
cipient aorta. (hom Starzl. Experience in Hepatic 
Transplantation, Courtesy of W. B. Saunders, Phila-
delphia, 1969,) 
Spatial problems. Not surprisingly, 
a homograft of exactly the right size may be 
difficult to find for any given recipient. Con-
sequently, major size disparities often have 
had to be accepted. There have been few dif-
ficulties in using undersized organs. For ex-
ample, it has been possible to carry out ortho-
topic transplantation of a 5-year-old liver to 
a full-sized adult. Other size mismatches 
nearly as extreme have been safe. 
On the other hand, serious risks are borne 
when the donor organ is disproportionately 
large. Size disparities in this direction may 
lead to compression of the blood supply 
(Fig. 16). This kind of complication tends to 
occur just as the abdomen is being closed, in 
which case an adverse chain of events leading 
to death may be set in motion, but not ap-
preciated, until it is too late for correction. 
Vascular anomalies. Anatomical vari-
ations of either the graft or host arteries have 
been encountered in almost 40 percent of 
our cases. Multiple arteries have been the 
most frequent anomalies (Fig. 14 B and C). 
When these have been found in the recipi-
ent, most commonly the graft celiac axis has 
been connected to the host aorta. "When the 
multiplicity has been of the transplant ves-
sels, multiple arterial anastomoses (Fig. 14 B) 
or other variant'procedures (Fig. 14 C and 
17) have been used. Unquestionahly, the 
need to improvise in these situations imposes 
an extra risk, particularly in the very young 
recipients ,\·hose arteries are quite small and 
thin-walled. In patients with biliary atresia, 
anomalies may be encountered of which the 
complexity may be so great as to make it vir-
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DONOR LIVER 
A. B. 
FIG. 17. Method of arterial reconstruction employed because of the presence of two homograft 
arteries. (A) The anomalous arterial supply in the donor. (8) The homogroft celiac axis was 
anastomosed to the common hepatic artery of the recipient. After blood flow was restared 
through the larger left branch, the homograft splenic ortery was ollached to the small right 
hepatic branch. C.d.-common duct; L.g.a.-Ieft gastric artery; L.h.a.-Ieft hepatic artery; 
M.h.a.-middle hepatic artery; R.h.a.-right hepatic art~ry; S.a.-splenic artery; S.m.a.-superior 
mesenteric artery. (From Storz!' Experience in Hepatic Transplantation, Courtesy of W. B. 
Sounders, Philadelphia, 1969.) 
tually impossible to succeed. Two of our in-
fants with biliary atresia had a curious type 
of malrotation in which the portal vein 
passed in front of the pancreas and duo-
denum, the arterial blood supply issuing 
from the superior mesenteric artery rather 
than from the celiac axis, which was absent. 
In addition, the retrohepatic inferior \'ena 
cava was missing. In both cases,3 corrective 
maneuvers to overcome the structural deficits 
Homograft liver 
y~~~~fF duodenostomy 
left 
duct 
FIG. 18. The anatomical basis for a technical error which cost the lives of two patients. Distal 
ligation of the double-barreled extrahepatic duct system resulted in total biliary obstruction. 
(From Starz!' Experience in Hepotic Transplantation, Courtesy of W. B. Sounders, Philadelphia, 
1969.) 
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FIG. 19. Method of choledochoduodenostomy employed in several recipients .. of liver homografts. 
After opening the duodenum, a short submucosal tunnel is formed, through which the 
homograft common bile duct is drawn. 
was unsuccessful and the patients died within 
a few days. 
Bile duct problems. An end-to-end 
anastomosis of the common duct, if it were 
normal, would have the advantage of pre-
serving the sphincter of Oddi, thus reducing 
the chances of reflux of food or bacteria. Of 
course, such an option is not available in re-
cipients with biliary atresia. In other kinds of 
cases, we believe that because of the factor of 
immunosuppression this anastomosis involves 
too high a risk of leakage and infection in 
the face of T tube stents and drains. Conse-
quently, the safer if some\\"hat less elegant 
technique is used of anastomosing the gall-
bladder directly to the duodenum and ligat-
ing the common duct (Fig. 14). By so doing, 
all stents and drains can be avoided. 
Ligation of the transplant common duct 
in conjunction "with cholecystoduodenostomy 
may be dangerous if there are unrecognized 
anomalies such as a septum between the 
cystic and common ducts. In two cases in our 
experience, biliary drainage was inadver-
tently obstructed when the common duct 
ligature closed both parallel passages (Fig. 
18), a technical error that subsequent surgery 
. failed to correct' and that pro,"ed fatal. 
'While choiecystocluodenostomy remains 
the preferred primary operation, the slightest 
suspicion that it will not proyide effective 
drainage for anatomical or other reasons 
should lead to a decision for an a1ternatiye 
technique. \Vith biliary atresia, choledocho-
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FIG. 20. Choledochoduodenostomy (continued). The common bile duct is then everted to form 
a nipple and its mucasa approximated ta that of the duodenum with fine silk sutures. 
Diaphragm 
Liver 
fiG. 21. Mechanism of operative injury of the right 
phrenic nerve. Note the indusion of the nerve with 
a portion of the diaphragm in the bite of the vas-
cular clamp placed across the suprahepatic vena 
cava. (Fram Storz!' Experience in Hepatic Trans-
plantaticn, Courtesy of W. B. Sounders, Philadel-
phia, 1969.) 
duodenostomy has been performed with the 
method depicted in Figures 19 and 20. In 
cases where a normal distal comnion duct is 
present, end-to·end choledochocholedochos-
tomy has been performed both with and 
without stenting by a T tube. 
Other operative problems. A long 
list of other technical pitfalls includes ve-
nous- infarction of the right adrenal gland 
secondary to sacrifice of the adrenal vein (see 
earlier), air embolism during recipient hepa-
tectomy, and crushing of the right phrenic 
nerve by clamps placed too superiorly on the 
upper vena caval cuff (Fig. 2]) to mention 
only three examples. A more detailed discus-
sion of these and other surgical problems has 
recently been published.3 
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NONIMMUNOLOGICAL 
POSTOPERATIVE 
COMPLICA TIONS 
Aberrations of Coagulation 
Earlier, the problems were discussed 
of an intraoperative bleeding diathesis sec-
ondary to hepatic insufficiency. The conse-
quenthemorrhage may continue unchecked 
into the postoperative period if the trans-
planted organ is of poor quality. On the 
other hand, the provision of a weU-function-
ing hepatic homograft will promptly correct 
the coagulation defect and there has been 
some evidence that a rebound hypercoagu-
ability may actually occur.l0 In every signifi-
cant series of liver transplantations, at least 
one example of a lethal thrombotic complica-
tion has been noted. These have included 
venous thrombosis of the legs with or with-
out pulmonary embolism. In addition, de-
layed thrombosis of the homograft hepatic 
artery or portal vein has occurred on several 
occasions. 
i 
( 
In a few early trials of liver transplanta-
tion, heparin was tried as a means of prevent-
ing postoperative thrombotic complications, 
but the hemorrhagic complications of anti-
coagulation were devastating in some of these 
recipients. Consequently, we now avoid iatro-
genic manipulation of the clotting process. 
after liver transplantation and use neither' 
thrombogenic nor anticoagulant agents. 
Delayed Biliary Obstruction 
For reasons already described, the 
most commonly used method of biliary duct 
reconstruction has been with cholecystoduo-
denostomy (Fig 22). In at least four patients 
who had satisfactory initial bile drainage 
with this reconstruction, delayed obstructive 
jaundice appeared which was diagnosed by 
the technique of cholangiography, illustrated 
in Figure 23. The point of obstruction was 
at or near the junction of the cystic and com-
mon ducts (Fig. 23). All four patients died iIll 
spite of the fact that two of them had sec-
ondary conversion of the cholecystoduodenos·, 
tomy to choledochoduodenostomy. 
The pathological findings in the gall-
bladder and biliary ducts of these homografts 
FIG. 22. Cholecystoduodenostomy. (Left) The gallbladder has been anastomosed to the duode-
num. (Right) Normal operative cholangiogram obtained by the technique shown in Figure 23. 
There is free passage of the contrast medium through the cystic duct. C.d.-cystic duct; C.H.D.-
Common hepatic duct; C.B.D.-common bile duct; GB-gallbladder. (From Martineau et 01. Surgery 
72:604, 1972. Courtesy of The C. V. Mosby Company, St. louis.) 
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FIG. 23. Cholangiography of hepatic homografts. (Left) Technique of dye injection through a 
duodenotomy and the anastomosis. (Right) Obstructed duct system in a liver recipient whose 
primary biliary reconstruction was with cholecystoduodenostomy. (From Martineau et aJ. 
Surgery 72:604, 1972. Courtesy of The C. V. Mosby Company, St. Louis.) 
were of great interest.ll The walls were in-
fested with cytomegalovirus (CMV), which 
had caused swelling and shedding of the epi-
thelial cells. Consequently, the etiology of 
this complication was at least partly infec-
tious and presumably secondary to the im-
munosuppression which is required in all 
such cases. 
Because of the background of· immuno-
suppression, the development of cholangitis 
secondary to mechanical duct obstruction has 
extremely serious implications in liver recipi-
ents. In both experimental animals and man, 
homograft cholangitis may lead to multiple 
intrahepatic abscesses which cannot be effec-
tively treated. Bacteremia results, usually 
with microorganisms that are indigenous to 
the intestinal tract (Fig. 24). All the manifes-
tations of gram-negative septicemia, including 
cardiovascular collapse, may follow. In fol-
lowing patients with li~Der transplantation 
through the postoperative period, blood cul-
tures are frequently obtained. If these be-
come positive, biliary duct obstruction or 
some other complication of the homograft 
such as devascularization should. be sus-
pected. 
Miscellaneous Complications 
Full recovery from anesthesia may be 
delayed in liver recipients, requiring ventila-
tory support for as long as I or 2 days after 
return to the intensive care center. Even 
after extubation, meticulous tracheobron-
chial toilet must be provided, including sys-
tematic nasotracheal suction. In spite of these 
precautions, early pneumonitis or atelectasis 
have been relatively common and a number 
of our patients have required bronchoscopy. 
Control of secretions has been a partieularly 
difficult task in those patients who suffered 
unilateral phrenic nerve injury intraopera-
tively (see Fig. 21). 
Gastrointestinal hemorrhage is a rather 
common complication of the steroid compo-
nent of the immunosuppressive regimen that 
all such organ recipients require. This has 
heen particularly well documented in the 
renal transplant population,S but the same 
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FIG. 24. An explanation for the predisposition of the 
liver to bacterial sepsis. Presumably the invading 
microorganisms enter via the portal vein or through 
the reconstructed biliary tract. (From Storz!' Ann. 
Surg. 168:392, 1968.) 
thing has been reported in liver recipients.3 
The mos t common etiology of the hemor-
rhage is peptic disease of the duodenum or 
stomach, but fatal gastrointestinal bleeding 
has resulted from enteritis caused by Can-
dida albicQlls infestation of the bowel wall. 
The same kind of fun;s,ll infection has also 
been responsible for at least one example of 
post-transplantation pancreatitis. In addi-
tion, a Humber of liYer recipients dying from 
a few days to more than a year after trans-
plantation have had histopathological find-
ings of idiopathic acute, subacutc, or chronic 
pancreatis. Pancreatitis is undoubtedly rc-
Iated at least in part to the need for chronic 
immunosuppression_ 
In children, arterial hypertension has been 
seen quite frequently. This has been attrib-
uted partly to the effects of steroid therapy 
but, in addition, the inability of the new 
liver to deal with pressor substrates may have 
contributed. For example, evidence has been 
t'eported 3 of defective tyramine degradation. 
Tyramine is an aromatic amine which is nor-
mally formed in the gastrointestinal tract by 
the decarboxylation· of tyrosine and which is 
then detoxified by hepatic monoamine oxi-
dase. T.he sympathomimetic properties of 
tyramine are thought to be by its induction 
of norepinephrine release from adrenergic 
nerve endings. 
IMl\mNOSUPPRESSION 
"\Vith the transplantation of any whole 
organ from other than an identical twin 
donor. a special problem must be dealt with. 
namely the prevention of rejection. Since the 
process of rejection is a manifestation of the 
immunological -defense of the host against 
antigens identified as "nons elf," its control 
depends upon the systematic weakening of 
the host defenses which ordinarily provide 
resistance against invasion by a wide spec-
trum of microorganIsms. 
Techniques of 
I mmunOSl1 ppression 
The therapeutic regimens that are 
used for hepatic recipients were evolved and 
tested in patients treated by renal homotrans-
plantation_ These treatment programs have 
been used essentially without modification 
for the liver recipients. 
Double drug therapy. The first pro-
tocol which was used for all organ recipients 
in most transplantation centers throughout 
the world consisted of "douhle drug' treat-
ment 3, 9 with azathioprine and the synthetic 
adrenal corticosteroid, prednisone. Evollltion 
of the use of these two agents together, ap-
preciation of their marked synergism, and 
demonstration that rejection could be easily 
reversed by increasing the steroid do,es were 
among the advances which made clinical 
VIAL 
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MORSE SERUM 
FIG. 25. The preparation of horse heterologous 
antilymphocyte globulin' for use in patients. (From 
Starzl. Christopher's Textbook of Surgery, Courtesy 
of W. B. Saunders, Philadelphia, 1968.) 
transplantation practical and which intro-
duced what is known as the modern era of 
this clinical field. But in spite of fair results 
with renal transplantation, the double drug 
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therapy either did not prevent rejection of 
hepatic homografts in the early trials or else 
it proved too toxic to permit host sun'ivaI. 
All patients treated with lh'er transplanta-
tion from '1963 to 1966 under this kind of 
treatment died in a month or less.3 
Triple drug therapy including ALG. 
In 1966, heterologous antilymphocyte globu-
lin (ALG) was introduced clinically at our 
center as a third immunosuppressive agent 
added to the drugs mentioned above.9 Since 
then, this "triple drug" therapy has been 
given to essentially all our renal, hepatic, 
and cardiac recipients. ALG is the globulin 
removed from the serum of an animal im-
munized against lymphoid tissue obtained 
from the species to be treated. Our greatest 
experience has been with ALG obtained 
from horses immunized against human 
lymphocytes (Fig. 25) . .It has seemed to us 
that rejection has been more easily and regu-
larly controlled and the risks and morbidity 
imposed by the necessity for high·dose steroid 
therapy have been reduced with the use of 
the triple drug program (Fig. 26). 
More recently, cyclophosphamide, a well-
known cancer chemotherapeutic agent with 
pot~nt cytotoxic properties, has been used 
~K~ 
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FIG. 26. The course of a patient who underwent a rejection crisis while under treatment with 
a triple drug program that included azathioprine, prednisone, and ALG. The rejection began 
on the sixth day, reached a peak within 2 days, and receded promptly. Gram-negative bac-
teremia w.as diagnosed from a blood specimen obtained on post-transplantation day 14. Note 
thot the immunosuppressive therapy was actually lightened with the development and evolution 
of the rejection crisis. 
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.FIG. 27. The course of a patient who had triple drug theropy with cyclophosphamide (instead 
of azathioprine), prednisone, and horse ALG. Note that there was excellent liver function except 
during the second and third postoperative months, when the patient developed iaundice and 
rises in the levels of the serum transaminases. These abnormalities were coincidental with the 
appearance of the Australia antigen in the serum and consequently were probably reflec-
tions of serum hepatitis rather than rejection. The recipient's original diagnosis was Wilson's 
disease. He is well B-2 years after transplantation. 
during the early postoperative period instead 
of azathioprine in the triple drug regimen. 
There are potential advantages to the use of 
cyclophosphamide, including the fact that it 
apparently has somewhat less hepatotoxicity 
than azathioprine. After 1 or 2 months, 
azathioprine has been substituted for cyclo-
phosphamide for maintenance treatment 
(Fig. 27). 
Manifestations of Rejection 
In spite of immunosuppressive ther-
apy, most patients develop some signs of he-
patic homograft rejection and usually these 
appear ·wi thin the first few postoperative 
weeks. Jaundice appears, with increases in 
both the: total and conjugated bilirubin, as 
might be expected ,dth biliary duct obstruc-
tion_ It has come to be recognized, however. 
that these biochemical mani[c,tations are a 
reflection of intrahepatic cholestasis. Conse-
quently, it is not surprising that sharp rises 
in tIte alkaline phosphatase also occur. 
Additional abnormalities in the liver func-
tion tests may indicate variable hepatic ne-
crosis. There are increases in the SCOT, 
SCPT. and the liver-specific enzyme, isocitric 
dehydrogenase_ The synthetic functions of 
the liver are surprisingiy well maintained 
even with advanced degrees of rejection. 
The findings of rejection occupy a wide 
spectrum of manifestations. The process may 
be very indolent, with jaundice being the 
main finding. or it can even be so mild that 
clinically obvious icterus never appears. At 
the other extreme. rejection may occur as an 
acute crisis (Fig. 26), with evidence of massive 
tissue necrosis. Then. bacteremia may com-
plicate matters. apparently as the result of 
seeding by bacteria of necrotic foci within 
the liver by a mechanism to be discussed 
later. 
Fortunately, rejection is a highly reversible 
process ,,-jth increased doses of steroids or 
sometimes ,,,-ithout any adjustment in ther-
apy at all (Fig. 26). After rejection is con-
trolled, it is often possible ultimately to 
reduce the amount of day-to-day immuno-
suppression that is required to pre\·ent a re-
currence. 
Penalties of 
I mmllllosup pression 
Risks 'with all organs. Heightened 
susceptibility to infection is the most obvious 
penalty of a depressed immune system. In 
the early COlllpilations of results in kidney 
transplant recipients, a repeated and often 
fatal chain of events was infection by bac-
teria, fungi, viruses, or even protozoa. vVhen 
these infections were caused by common 
pathogenic bacteria against -which effective 
antibiotics were available, treatment was usu-
ally not difficult. Infection with opportunis-
tic fungi or other microorganisms for which 
antibiotics are not available emerged as the 
most serious late problem after transplanta-
tion, however. 
It has also become obvious 3, 12 that chron-
ically immunosuppressed patients have an 
increased vulnerability to de novo malignant 
conditions. In our own series of chronic sur-
vivors after renal transplantation, more than 
5 percent have developed either mesenchymal 
or epithelial malignant tumors. Almost all 
other major transplantation cerHers have re-
corded this same complication, which is pre-
sumably due to failure of the depressed 
immunological surveillance mechanism to 
identify mutant neoplastic cells as alien and 
to eliminate them or to restrict their growth. 
Fortunately, the'se tumors can usually be 
treated by conventional means, including 
surgical excision and radiotherapy. 
To date, there have not yet been any ex-
amples of de novo malignancy in chronically 
surviving recipients of hepatic homografts. 
As l1as already been noted in an earlier sec-
tion, however, there has been an almost uni-
versal recurrence of tumors in patients whose 
indication for hepatic. replacement was the 
presence of an otherwise nonresectable hepa-
toma. The regular and often rapidly growing 
recurrences in these cases may conceivably 
ha\'e been contributed to by the loss of full 
immunological defense. 
Extra risks for liver recipients. In 
addition to the foregoing general liabilities 
. of immunosuppression, there are some special 
risks for the liver recipient. Of the chronic 
sun'ivors after hepatic transplantation in our 
center, about one-third have developed some 
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serological evidence of serum hepatitis by 
tests for thc Australia antigen (Fig. 27). In 
other liver recipients, hepatotoxicity of the 
immunosuppressivc drugs rather than uncon-
trolled rejection may ha"e been responsible 
for deterioration of graft function, althou,;h 
this possibility has been difficult to prow. 
'With liver malfunction, whateyer its cause, 
dose control of some of the immunosuppres-
sive agents may become difficult, since the 
liver participates in their path\\"ays of action 
and/or degradation. 
In the liver recipient, postoperative sepsis 
of the graft itself has proved to be a special 
problem, without doubt partly because of the 
anatomical location of the orthotopic ally 
placed organ, interposed bet,,"een the intesti-
nal tract and the heart. Bacteria from the 
bowel, particularly of the gram-negative vari-
ety, can thus be brought into contact with 
the transplanted liver via the intestinal veins 
draining into the portal vein or alternati,"ely 
by retrograde spread up the duct system after 
passage through the biliary anastomosis. In 
either event, the presence of nonyiable he-
patic tissue provides a perfect medium for 
bacteriological growth and then systemic dis-
semination (Fig. 24). Almost paradoxically," 
on~ of the most important ways by which 
hepatic sepsis can be avoided is to administer 
heavy doses of steroids in the early postopera-
tive period, thereby circumventing rejection 
episodes and consequent tissue ischemia. In 
addition, heavy antibiotic treatment is indi-
cated for the first postoperative week, includ-
ing agents effective against gram-negath-e 
bacteria. 
CLINICAL RESULTS 
Our own experience, including all pa-
tients treated with orthotopic 1iYer trans-
plantation from March 1963 until July 1971, 
12 months ago, has consisted of 46 cases. 
Survival of at least 1 year has been obtained 
in 12 of the 46 recipi~ntsK 
After 1 year, eight patients were lost for 
the reasons and the times shm\'n in Table 2 . 
The causes of late failure were carcinomato-
sis (three examples), late or chronic homo-
graft rejection (three examples), and serum 
hepatitis (two examples). Deaths have oc-
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Table 2. TWELVE I-YEAR SURVIVORS 
AFTER ORTHOTOPIC 
LIVER TRANSPLANTATION 
Alive 
Died 
4/12 
8/12 
12 Months - Cancef"'l 
1 to 3 years 
1 to 3Y2 years 
12 Months - Serum hepatitis, liver failure 
14 Months - Cancer 
15 Months - Cancer 
15 Months - Rejection, liver failure 
20 Months - Chronic aggressive hepatitis and 
disseminated nocardia infectionb 
30 Months - Rejection, liver failure 
42 Months - ? Rejection, liver failure 
aThis patient actually died a few days short of 1 year 
bThe homograft showed severe chronic aggressive hepa-
titis, just as in her previously removed native liver 
curred as long as 3Y2 years after operation. 
In view of the serious implications of 
serum hepatitis in liver transplant recipients, 
it could be questioned if liver transplanta-
tion would offer any hope in the treatment 
of lethal serum hepatitis. In one extraordi-
nary patient whose reason for transplanta-
tion was chronic aggressive hepatitis, Austra-
lia antigen positive, life was definitely pro-
. longed by the provision of a new liver. 
Transplantation was carried out in the 
summer of 1970. The Australia antigen be-
came negative for almost 2 months and then 
returned to positive at the same time as a 
clinically obvious bout of acute serum hepa-
titis. She recovered from this but her Austra-
lia antigen remained positive until she died 
of recurrent chronic aggressive hepatitis 20 
months later. X evertheless, her health was 
satisfactory for all but the last month or so 
of her survival. 
The experience in treating hoth hepatoma 
and serum hepatitis has demonstrated how 
adversely the original disease can affect the 
ultimate outcome. Such should not be the 
case with inhorn errors of metaholism, pro-
viding the new liver can compensate fot 
preexisting metabolic defects. Two of our 
patients haye had liYer replacement for 'ViI-
son's disease, a disorder characterized by 
widespread tissue copper accumulation. Both 
are alive with excellent ]jYer function after 
3 and 1 Y2 years. Copper storage in their 
homografts has not occurred_ 
Similarly, the course after liver transplan-
tation should not be affected by the previous 
diagnosis of congenital biliary atresia. Six 
(32 percent) of our 19 patients with biliary 
atresia lived for more than 1 year after trans-
plantation. The high mortality rate in these 
cases had a heavy contribution from techni-
. cal factors of which many were related to the 
small size of the structures being anasto-
mosed. 
So far, the most discouraging results of all 
have been with Laennec's cirrhosis, primarily 
because of the debilitated condition of the 
patients. To date, extended survival has not 
been obtained after transplantation for this 
disease, while at the same time patients with 
cirrhosis from other causes have lived for 
long times. 
FUTURE PROSPECTS 
Earlier in this chapter, the contribu-
tion of structural anomalies to technical fail-
ure was mentioned. The accurate identifica-
tion of such variations in advance of opera-
tion, both in the donor and recipient, is 
useful. Recently, a very ·.much wider use of 
angiography and cholangiography preopera-
tively and intraoperatively has reduced the 
number of technical surgical accidents. 
So far the least satisfactory surgical detail 
of liver transplantation has been the pro-
vision of bile drainage, at least six early 
deaths in our series having been due to acute 
or delayed biliary obstruction_ In the future, 
prompt reexploration of the homograft duct 
system should be carried out if there is any 
suspicion of obstruction. Procrastination in 
past cases has permitted the development of 
fatal intrahepatic sepsis. 
In addition to improving the technical per-
formance of liver transplantation, the use of 
immunosuppressive drugs -with low hepato-
toxicity may prove to be helpful, and it was 
with this objective that the substitution of 
cyclophosphamide for azathioprine ,vas un-
dertaken. This major change in therapy will 
require much more evaluation before it can 
be generally recommended. E\·en now it 
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seems clear, however, that cyclophosphamide 
is equivalent in its immunosuppressive action 
to azathioprine. \ Vith this new therapeutic 
regimen, five patients have been treated with 
liver transplantation in 1972. 'With foIl ow-
ups of ,1 to 8 months, four of these recipients 
are well. The fifth died of a technical com-
plication. 
The history of hepatic transplantation 
viewed 10 years hence is apt to be very simi-
lar to that of renal transplantation viewed 
now from a lO-year retrospective vantage. 
The feasibility stage of hepatic transplanta-
tion has long since been passed, since there 
have now been two patients who have sur-
vived for as long as 3Y2 years after this oper-
ation, one in our series and the other re-
ported by Professor Roy CaIne of Cambridge. 
The inconsistent results so far obtained will 
undoubtedly improve; particularly if patients 
are accepted before the terminal stages of 
their disease, as has been the practice until 
recently. It seems certain that liver trans-
plantation will become as much a part of the 
therapeutic armamentarium for the treat-
ment of hepatic disease as the analogous op-
eration kidney transplantation has become 
in the treatment of kidney disorders. 
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A. HYDATID DISEASE OF THE LIVER 
AND OTHER VISCERA 
BASILE G. KOURIAS 
This chapter is dedicated to the memory of two eminent investigat01's of hydatid 
disease: to Si,- Harold Dew, who, for over 20 years, was the author of this chapter 
in its various editions, and to the great pioneer, the grand maitre of hydatid dis-
ease, Pmfessor Felix Deve 
Today, hydatid disease interests not only 
surgeons of the countries where the disease 
is endemic but also medical men throughout 
the world. The alienation of vast numbers 
of people from country to country during the 
past 30 years, either during war or peace, 
has made infestation become more prevalent 
than at any previous time. Thus, such pa-
tients are being operated' upon in many 
countries_ 
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